Insider filing · ADPT
Sharon Benzeno
Chief Commercial Ofc Imm Med
profile →
Adaptive Biotechnologies Corporation
ADPT · Healthcare · 80 filings in 24 months
ticker →
Sharon Benzeno sold $10.1M of Adaptive Biotechnologies (ADPT)
Executed Nov 20 2025, disclosed Nov 24 2025, 4 days later.
Value, as filed
$10.1M
606,402 sh across 2 lots
Executed
Nov 20 2025
the trade date, as filed
Disclosed
Nov 24 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SBSharon Benzeno (Chief Commercial Ofc Imm Med) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Adaptive Biotechnologies Corporation (ADPT). The largest single filing was $10.1M of ADPT (606,402 sh across 2 lots, as filed), executed Nov 20 2025.
The name
ADPTHealthcare · Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of v…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Sharon Benzeno in ADPT
ADPTSALE
Adaptive Biotechnologies Corporation
$3.5M165,802 sh across 2 lots
Exec Jun 26
Filed Jun 30 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $831K
63,103 sh × $13.17
Exec Mar 11
Filed Mar 13 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $212K
12,604 sh × $16.85
Exec Dec 4 2025
Filed Dec 8 2025 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $290K
41,600 sh × $6.98
Exec Mar 5 2025
Filed Mar 6 2025 · 5:30 PM ET